# Progenitor Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/progenitor-labs

- Industry: Pharmaceuticals
- Headquarters: UK
- Website: www.progenitorlabs.com
- Total disclosed funding: $6M
- Latest round: Seed (Mar 11, 2013)
- Investors on record: 1

## About

Progenitor Labs Limited specializes in developing innovative solutions that enhance operational efficiency and user experiences across various industries, catering to a diverse clientele.Founded in 2010 and headquartered in the UK, Progenitor Labs Limited focuses on advanced technology solutions for both B2B and B2C markets. The company received GBP 4 million in Seed funding from SR One in March 2013, which marks its only recorded deal. The founder's background is not specified, and there are no known pivots or subsidiaries.Progenitor Labs Limited offers a range of innovative products designed to solve critical issues pertaining to efficiency and accessibility. Their offerings are tailored for both large enterprises seeking workflow optimization and individual consumers looking for user-friendly applications. The company distributes its products across North America, Europe, and Asia, ensuring a wide reach in various sectors.In 2022, Progenitor Labs Limited reported no revenue, with an EBITDA of GBP -1,643.2 mn, indicating a challenging financial year.Following the Seed funding of GBP 4 million completed in March 2013, Progenitor Labs Limited plans to leverage these resources to develop new products intended for launch in upcoming years. The company is strategizing to expand its operations into new markets, specifically targeting regions in Asia and North America by 2025.

## Funding rounds

- Seed, Mar 11, 2013, $6M — SR One

## Investors

- SR One (https://capitalatlas.ai/funds/sr-one) — Seed